XNCR
Xencor, Inc.
NASDAQ · USHealthcareBiotechnology
$18.81+7.67%
Price as of Jul 20, 2026
XNCR profitability
Xencor, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 36.2%
- EBITDA margin
- -135.2%
- EBIT margin
- -217.9%
- Net margin
- -177.1%
- Free cash flow margin
- -194.0%
Returns
- Return on equity
- -33.4%
- Return on assets
- -23.4%
- Return on invested capital
- -30.7%
- Asset turnover
- 0.12x
Cash efficiency
- Cash from operations
- -$186.5M
- Cash per share
- $6.00
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.